Lantern Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>LP</div>
LTRN -- USA Stock  

USD 17.50  0.03  0.17%

Lantern Stock News module provides quick insight into current market opportunities from investing in Lantern Pharma. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Lantern Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Additionally, see Lantern Pharma Hype Analysis, Lantern Pharma Correlation and Lantern Pharma Performance.

Search Today's Stock News

 
Refresh
Lantern Pharma stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lantern daily returns and investor perception about the current pice of Lantern Pharma as well as its diversification or hedging effects on your existing portfolios.
Conversion by Green Park Golf Ventures Ii Llc of 75688 shares of Lantern Pharma
Filed transaction by Lantern Pharma Inc executive. Derivative codes conversion of derivative security

Lantern insider trading alert for conversion of series a preferred stock par value $0.01 by Green Park Golf Ventures Ii Llc, the corporate stakeholder, on 17th of June 2020. This event was filed by Lantern Pharma Inc with SEC on 2020-06-17. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Number of Shares Shorted

Number of Shares Shorted Comparative Analysis

Lantern Pharma is currently under evaluation in number of shares shorted category among related companies. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Peers

Lantern Pharma Related Equities

EDITEditas Medicine   0.84   
14.0%
NKNantKwest   2.31   
40.0%
DNLIDenali Therapeutics   2.51   
44.0%
EQEquillium   2.73   
48.0%
DVAXDynavax Technologies Corporation   2.82   
49.0%
EARSAuris Medical Holding   3.19   
56.0%
DTILPrecision BioSciences   3.34   
58.0%
DYAIDYADIC INTERNATIONAL INC   3.45   
60.0%
DRNADicerna Pharmaceuticals   4.64   
81.0%
DMACDiaMedica Therapeutics   5.69   
100.0%
Additionally, see Lantern Pharma Hype Analysis, Lantern Pharma Correlation and Lantern Pharma Performance. Please also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..